Pharmacyte Biotech Inc (PMCB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 04/30
| 04-2016 | 04-2015 | 04-2014 | 04-2013 | 04-2012 | |
| Sales | 0 | 0 | 0 | 12 | 67 |
| Cost of Goods | N/A | N/A | N/A | 10 | 19 |
| Gross Profit | N/A | N/A | N/A | 3 | 47 |
| Operating Expenses | 6,073 | 13,261 | 18,979 | 1,697 | 2,016 |
| Operating Income | -6,073 | -13,261 | -18,979 | -1,684 | -1,949 |
| Interest Expense | 1 | 5 | 20 | 154 | 241 |
| Other Income | 11 | 3,338 | -8,255 | 241 | 291 |
| Pre-tax Income | -6,064 | -9,928 | -27,254 | -1,598 | -1,899 |
| Net Income Continuous | -6,064 | -9,928 | -27,254 | -1,598 | -1,899 |
| Net Income | $-6,064 | $-9,928 | $-27,254 | $-1,598 | $-1,899 |
| EPS Basic Total Ops | -14.29 | -14.29 | -71.43 | 0.00 | -14.29 |
| EPS Basic Continuous Ops | -11.51 | -20.14 | -66.76 | -5.18 | -7.24 |
| EPS Diluted Total Ops | -14.29 | -14.29 | -71.43 | 0.00 | -14.29 |
| EPS Diluted Continuous Ops | -11.51 | -20.14 | -66.76 | -5.18 | -7.24 |
| EBITDA(a) | $-6,073 | $-13,261 | $-18,979 | $-1,690 | $-1,935 |